Literature DB >> 6816243

Modification of anti-inflammatory drug effectiveness by ambient lipid peroxides.

A M Hanel, W E Lands.   

Abstract

When the steady-state concentrations of peroxide in prostaglandin H synthase assay systems was lowered by added glutathione peroxidase, several agents (meclofenamic acid, mefenamic acid, acetamidophenol and phenylbutazone) became more potent inhibitors of the prostaglandin-forming cyclooxygenase reaction. Paradoxically, these agents stimulated oxygen incorporation in the absence of added peroxidase. On the other hand, dithiothreitol, ibuprofen, flurbiprofen and indomethacin all inhibited the reaction in a dose-dependent manner, and their inhibitory potencies were unaffected by the action of glutathione peroxidase. Aspirin, dl-gamma-tocopherol and salicylic acid were not inhibitory (without preincubation) under the assay conditions employed in this study. The findings demonstrate that the potencies of some anti-inflammatory agents may be diminished by high local peroxide concentrations.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6816243     DOI: 10.1016/0006-2952(82)90565-2

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  13 in total

Review 1.  Learning how membrane fatty acids affect cardiovascular integrity.

Authors:  William E M Lands
Journal:  J Membr Biol       Date:  2005-07       Impact factor: 1.843

Review 2.  Paracetamol: new vistas of an old drug.

Authors:  Alfio Bertolini; Anna Ferrari; Alessandra Ottani; Simona Guerzoni; Raffaella Tacchi; Sheila Leone
Journal:  CNS Drug Rev       Date:  2006 Fall-Winter

3.  Cyclooxygenase expression and prostaglandin levels in central nervous system tissues during the course of chronic relapsing experimental autoimmune encephalomyelitis (EAE).

Authors:  Samir S Ayoub; Elizabeth G Wood; Sabih-Ul Hassan; Christopher Bolton
Journal:  Inflamm Res       Date:  2011-06-12       Impact factor: 4.575

4.  Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandin H(2) synthases.

Authors:  Olivier Boutaud; David M Aronoff; Jacob H Richardson; Lawrence J Marnett; John A Oates
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

5.  The antinociceptive activity of paracetamol in zymosan-induced peritonitis in mice: the role of prostacyclin and reactive oxygen species.

Authors:  N S Doherty; T H Beaver; K Y Chan; R J Dinerstein; K A Diekema
Journal:  Br J Pharmacol       Date:  1990-12       Impact factor: 8.739

6.  Acetaminophen inhibits hemoprotein-catalyzed lipid peroxidation and attenuates rhabdomyolysis-induced renal failure.

Authors:  Olivier Boutaud; Kevin P Moore; Brandon J Reeder; David Harry; Alexander J Howie; Shuhe Wang; Clare K Carney; Tina S Masterson; Taneem Amin; David W Wright; Michael T Wilson; John A Oates; L Jackson Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-01       Impact factor: 11.205

Review 7.  Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action.

Authors:  Samir S Ayoub
Journal:  Temperature (Austin)       Date:  2021-03-16

8.  Detergents profoundly affect inhibitor potencies against both cyclo-oxygenase isoforms.

Authors:  Marc Ouellet; Jean-Pierre Falgueyret; M David Percival
Journal:  Biochem J       Date:  2004-02-01       Impact factor: 3.857

Review 9.  The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings.

Authors:  Garry G Graham; Michael J Davies; Richard O Day; Anthoulla Mohamudally; Kieran F Scott
Journal:  Inflammopharmacology       Date:  2013-05-30       Impact factor: 4.473

Review 10.  Pharmacological hypotheses: Is acetaminophen selective in its cyclooxygenase inhibition?

Authors:  Christopher J Esh; Bryna C R Chrismas; Alexis R Mauger; Lee Taylor
Journal:  Pharmacol Res Perspect       Date:  2021-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.